Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125976581 | 12597658 | 1 | I | 20160422 | 20160718 | 20160727 | 20160727 | EXP | GB-MHRA-MIDB-74676D86-FE19-4466-BF2B-9D6EBD613957 | GB-MYLANLABS-2016M1029846 | MYLAN | 0.00 | Y | 0.00000 | 20160727 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125976581 | 12597658 | 1 | PS | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | UNK | 202650 | |||||||||||
| 125976581 | 12597658 | 2 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, QD (AT NIGHT.) | U | 0 | 100 | MG | QD | ||||||
| 125976581 | 12597658 | 3 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 25 MG, QD | U | 0 | 25 | MG | QD | ||||||
| 125976581 | 12597658 | 4 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 125976581 | 12597658 | 5 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Topical | UNK (APPLY THINLY TWICE A DAY AS DIRECTED.) | U | 0 | |||||||||
| 125976581 | 12597658 | 6 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 150 ?G, QD (100 AND 50 MICROGRAM TABLETS.) | U | 0 | 150 | UG | QD | ||||||
| 125976581 | 12597658 | 7 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | 45 MG, QD (AT NIGHT) | U | 0 | 45 | MG | QD | ||||||
| 125976581 | 12597658 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, QD (IN THE MORNING.) | U | 0 | 20 | MG | QD | ||||||
| 125976581 | 12597658 | 9 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 1 G, QID | U | 0 | 1 | G | QID | ||||||
| 125976581 | 12597658 | 10 | C | PERINDOPRIL | PERINDOPRIL | 1 | Oral | 8 MG, QD | U | 0 | 8 | MG | QD | ||||||
| 125976581 | 12597658 | 11 | C | LYRICA | PREGABALIN | 1 | Oral | 300 MG, BID | U | 0 | 300 | MG | BID |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125976581 | 12597658 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125976581 | 12597658 | Asthenia | |
| 125976581 | 12597658 | Balance disorder | |
| 125976581 | 12597658 | Headache | |
| 125976581 | 12597658 | Influenza like illness | |
| 125976581 | 12597658 | Myalgia | |
| 125976581 | 12597658 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125976581 | 12597658 | 1 | 20160421 | 20160421 | 0 |